Kisqali Femara Co-Pack Interactions
There are 730 drugs known to interact with Kisqali Femara Co-Pack (letrozole/ribociclib), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 319 are major, 398 are moderate, and 13 are minor.
- View all 730 medications that may interact with Kisqali Femara Co-Pack
- View Kisqali Femara Co-Pack alcohol/food interactions (2)
- View Kisqali Femara Co-Pack disease interactions (9)
Most frequently checked interactions
View interaction reports for Kisqali Femara Co-Pack (letrozole / ribociclib) and the medicines listed below.
- baclofen
- biotin
- calcium citrate
- Coenzyme Q10 (ubiquinone)
- Cytoxan (cyclophosphamide)
- diosmin
- Eliquis (apixaban)
- Evenity (romosozumab)
- gabapentin
- glucosamine
- hydrochlorothiazide
- lorazepam
- lutein
- multivitamin
- naproxen
- omeprazole
- ondansetron
- oxycodone
- pantoprazole
- Prolia (denosumab)
- promethazine
- propranolol
- Taxol (paclitaxel)
- tizanidine
- Tylenol Extra Strength (acetaminophen)
- venlafaxine
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
Kisqali Femara Co-Pack alcohol/food interactions
There are 2 alcohol/food interactions with Kisqali Femara Co-Pack (letrozole / ribociclib).
Kisqali Femara Co-Pack disease interactions
There are 9 disease interactions with Kisqali Femara Co-Pack (letrozole / ribociclib) which include:
- liver disease
- Ribociclib – arrhythmias
- cholesterol
- osteoporosis
- lung toxicity
- cutaneous toxicity
- hepatic impairment
- neutropenia
- renal impairment
More about Kisqali Femara Co-Pack (letrozole / ribociclib)
- Kisqali Femara Co-Pack consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.